House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political spectrum.
By Ricardo Alonso-Zaldivar, Associated Press
If Republicans prevail in just two races on Tuesday, the Senate’s ranks would suddenly include two former drug industry lobbyists and a pharma CEO.
By Lev Facher, STAT
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.